ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Leonard N. Girardi
Robert J. Ginsberg
Michael E. Burt
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Girardi, L. N.
Right arrow Articles by Burt, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Girardi, L. N.
Right arrow Articles by Burt, M. E.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1997;64:1422-1427
© 1997 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Pericardiocentesis and Intrapericardial Sclerosis: Effective Therapy for Malignant Pericardial Effusions

Leonard N. Girardi, MD, Robert J. Ginsberg, MD, Michael E. Burt, MD, PhD

Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

Background. Pericardial effusions remain a formidable problem in patients with an advanced malignancy. We reviewed our experience with pericardiocentesis and intrapericardial sclerotherapy versus open surgical drainage as the treatment for these effusions.

Methods. A retrospective review was performed of one surgeon's experience (M.E.B.) with the surgical treatment of malignant pericardial effusions at a tertiary-care cancer center.

Results. Sixty patients underwent 72 procedures during 8 years. Thirty-seven (51%) pericardiocenteses and 35 (49%) open procedures were performed in patients with effusions. There was no significant difference in the complication rates seen between those effusions drained via pericardiocentesis (n = 5; 13%) and those drained in an open surgical procedure (n = 5; 14%). Similar results were seen with respect to the development of a recurrent effusion. There were no procedure-related deaths. The median survival for all patients was 97 days. Patients with breast cancer as their primary malignancy survived significantly longer after drainage than did all others (p = 0.01). The type of procedure did not influence survival. Costs of surgical drainage exceed those of pericardiocentesis by nearly fortyfold.

Conclusions. Pericardiocentesis with intrapericardial sclerotherapy is as effective as open surgical drainage for the management of malignant pericardial effusions.


Related Article

Discussion
Ann. Thorac. Surg. 1997 64: 1427. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
J. L. Gross, R. N. Younes, D. Deheinzelin, A. L. Diniz, R. A. da Silva, and F. J. Haddad
Surgical Management of Symptomatic Pericardial Effusion in Patients with Solid Malignancies
Ann. Surg. Oncol., December 1, 2006; 13(12): 1732 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Martinoni, C. M. Cipolla, D. Cardinale, M. Civelli, G. Lamantia, M. Colleoni, and C. Fiorentini
Long-term Results of Intrapericardial Chemotherapeutic Treatment of Malignant Pericardial Effusions With Thiotepa
Chest, November 1, 2004; 126(5): 1412 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. M. Frankel, F. W. Grannis Jr, C. A. Cullinane, and I. B. Paz
Malignant Pericardial Effusions
Chest, November 1, 2004; 126(5): 1713 - 1713.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al.
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
Eur. Heart J., April 1, 2004; 25(7): 587 - 610.
[Full Text] [PDF]

Home page
 Ann OncolHome page
K. Reynen, U. Kockeritz, and R. H. Strasser
Metastases to the heart
Ann. Onc., March 1, 2004; 15(3): 375 - 381.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. M. McDonald, B. F. Meyers, T. J. Guthrie, R. J. Battafarano, J. D. Cooper, and G. A. Patterson
Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion
Ann. Thorac. Surg., September 1, 2003; 76(3): 811 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. L. Buchanan, V. V. Sullivan, R. Lampman, and M. G. Kulkarni
Pericardiocentesis with extended catheter drainage: an effective therapy
Ann. Thorac. Surg., September 1, 2003; 76(3): 817 - 820.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. M. Frankel
Treating Malignancy-Related Effusions
Chest, May 1, 2003; 123(5): 1775 - 1775.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
B. Maisch, A.D. Ristic, S. Pankuweit, A. Neubauer, and R. Moll
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin
Eur. Heart J., October 2, 2002; 23(20): 1625 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
A. Leung Wai Suen, L. S. Ho, N. Y. Chan, M. T. Chan, H. H. Tsang, and M. F. Kwok
Techniques and Outcomes of Two Modes of Pericardial Drainage
Asian Cardiovasc Thorac Ann, December 1, 1999; 7(4): 292 - 296.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The Society of Thoracic Surgeons.